Blog
RSS FeedPosted by Michael Wonder on 17 Oct 2023
A test could have saved Alison from chemotherapy
17 October 2023 - Chemotherapy. Radiotherapy. Surgery. These are the cancer treatments most people are familiar with. But advocates, patients ...
Posted by Michael Wonder on 16 Oct 2023
Cheaper medicines for cervical cancer, urotherial cancer and spinal muscular atrophy
16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access ...
Posted by Michael Wonder on 13 Oct 2023
Outcomes of the September 2023 PBAC intracycle meeting
13 October 2023 - The outcomes from the September 2023 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 11 Oct 2023
Updates to the HTA Policy and Methods Review Reference Committee (October 2023)
11 October 2023 - The draft paper Horizon Scanning and Early Assessment developed to support the deliberations of the HTA ...
Posted by Michael Wonder on 08 Oct 2023
Shingles vaccine now free for nearly 5 million Australians
8 October 2023 - From 1 November 2023, older Australians will have free access to the best protection against shingles through ...
Posted by Michael Wonder on 05 Oct 2023
Building a stronger Medicare with MyMedicare now open to patients
5 October 2023 - The Australian Government is laying the foundations for a stronger Medicare, with the new MyMedicare program open ...
Posted by Michael Wonder on 30 Sep 2023
Schedule of Pharmaceutical Benefits - 1 October 2023
1 October 2023 - The October 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Sep 2023
Akebia announces approval of Vafseo (vadadustat) in Australia
26 September 2023 - Akebia Therapeutics today announced that Australia's TGA has granted approval for Vafseo (vadadustat), an oral hypoxia-inducible ...
Posted by Michael Wonder on 27 Sep 2023
Agenda for November 2023 PBAC meeting – 25 September 2023 update
27 September 2023 - The agenda for the November 2023 meeting has been updated yet again. ...
Posted by Michael Wonder on 27 Sep 2023
Expanded medicines for breast cancer and leukaemia on the PBS
26 September 2023 - From 1 September 2023, Australians with an aggressive form of breast cancer and certain types of leukaemia ...
Posted by Michael Wonder on 26 Sep 2023
Updates to the HTA Policy and Methods Review Reference Committee – 26 September 2023
26 September 2023 - The agenda for this week's HTA Review Reference Committee meeting is now available. ...
Posted by Michael Wonder on 24 Sep 2023
New rules for weight loss ‘wonder drug’ after regulator clamp down
23 September 2023 - Australia’s pharmaceuticals regulator has ushered in new rules for a diabetes drug, which is being hailed by ...
Posted by Michael Wonder on 21 Sep 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – 22 September 2023
21 September 2023 - The agenda for this week's HTA Review Reference Committee meeting is now available. ...
Posted by Michael Wonder on 20 Sep 2023
International HTA collaboration expands
20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
Posted by Michael Wonder on 18 Sep 2023
Australian made cancer drug gets billion dollar US FDA approval
19 September 2023 - A drug invented in Melbourne to treat a lethal bone marrow cancer is set to become ...